Original Research

Published on 12 Apr 2023

A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer

in Genitourinary Oncology

Hajar Hasannejadasl
Biche Osong
Inigo Bermejo
Henk van der Poel
Ben Vanneste
Joep van Roermund
Katja Aben
Zhen Zhang
Lambertus Kiemeney
Inge Van Oort

Frontiers in Oncology

doi 10.3389/fonc.2023.1168219

1,613 views
1 citation

Original Research

Published on 11 Apr 2023

Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours

in Genitourinary Oncology

Peter Lesko
Barbora Vlkova
Katarina Kalavska
Valentina De Angelis
Vera Novotna
Jana Obertova
Zuzana Orszaghova
Patrik Palacka
Katarina Rejlekova
Zuzana Sycova-Mila

Frontiers in Oncology

doi 10.3389/fonc.2023.1149432

1,039 views
1 citation

Systematic Review

Published on 05 Apr 2023

Erectile function, urinary continence and oncologic outcomes of neurovascular bundle sparing robot-assisted radical prostatectomy for high-risk prostate cancer: A systematic review and meta-analysis

in Genitourinary Oncology

Yang Liu
Xian-zhong Deng
Jiao Qin
Zhi Wen
Yu Jiang
Jing Huang
Chong-jian Wang
Cai-xia Chen
Li Wang
Kun-peng Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1161544

1,177 views

Original Research

Published on 05 Apr 2023

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

in Genitourinary Oncology

Tanya Jindal
Xiaolin Zhu
Rohit Bose
Vipul Kumar
Edward Maldonado
Prianka Deshmukh
Chase Shipp
Stephanie Feng
Michelle S. Johnson
Austin Angelidakis

Frontiers in Oncology

doi 10.3389/fonc.2023.1161089

1,815 views

Editorial

Published on 04 Apr 2023

Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer

in Genitourinary Oncology

Felix Preisser
Michele Marchioni

Frontiers in Oncology

doi 10.3389/fonc.2023.1191543

479 views

Original Research

Published on 03 Apr 2023

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland

in Genitourinary Oncology

Dawid Sigorski
Michał Wilk
Angelika Gawlik-Urban
Agata Sałek-Zań
Joanna Kiszka
Mateusz Malik
Katarzyna Czerko
Kamil Kuć
Cezary Szczylik
Tomasz Kubiatowski

Frontiers in Oncology

doi 10.3389/fonc.2023.1108937

1,705 views

Original Research

Published on 03 Apr 2023

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer

in Genitourinary Oncology

Zhaojun Yu
Haichao Chao
Fanghua Xu
Huanhuan Deng
Leihong Deng
Zhen Song
Tao Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1115718

1,723 views
2 citations

Original Research

Published on 30 Mar 2023

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma

in Genitourinary Oncology

Dongxu Lin
Bintao Hu
Shiqing Zhu
Yue Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1131473

1,863 views

Case Report

Published on 30 Mar 2023

Primary squamous cell carcinoma of renal parenchyma: A case report and literature review

in Genitourinary Oncology

Ke Liang
Yichu Yuan
Bodong Lv
Zunjin Ke

Frontiers in Oncology

doi 10.3389/fonc.2023.1037156

1,243 views

Case Report

Published on 30 Mar 2023

Malignant glomus tumor of prostate: A case report

in Genitourinary Oncology

Zhanxin Sun
Fuzhen Sun
Chunhong Yu
Helong Xiao
Qingle Xu
Bo Gao
Liuxiong Guo
Junjiang Liu
Shoubin Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1121307

711 views

Original Research

Published on 29 Mar 2023

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

in Genitourinary Oncology

Margaret F. Meagher
Maria C. Mir
Andrea Minervini
Maximilian Kriegmair
Matthias Heck
Francesco Porpiglia
Siska Van Bruwaene
Estefania Linares
Vital Hevia
Maurizio D’Anna

Frontiers in Oncology

doi 10.3389/fonc.2023.1113246

909 views

Review

Published on 29 Mar 2023

Identifying novel biomarkers associated with bladder cancer treatment outcomes

in Genitourinary Oncology

Peris R. Castaneda
Dan Theodorescu
Charles J. Rosser
Michael Ahdoot

Frontiers in Oncology

doi 10.3389/fonc.2023.1114203

2,394 views
4 citations

Original Research

Published on 29 Mar 2023

Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer

in Genitourinary Oncology

Xi Xiong
Chen Chen
Xinxin Li
Jun Yang
Wei Zhang
Xiong Wang
Hong Zhang
Min Peng
Lili Li
Pengcheng Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.972558

1,769 views
3 citations

Original Research

Published on 27 Mar 2023

Risk of malignancy in adrenal tumors in patients with a history of cancer

in Genitourinary Oncology

Radosław Samsel
Karolina Nowak
Lucyna Papierska
Edyta Karpeta
Katarzyna Roszkowska-Purska
Wacław Smiertka
Tomasz Ostrowski
Eryk Chrapowicki
Alan Grabowski
Dorota Leszczyńska

Frontiers in Oncology

doi 10.3389/fonc.2023.1018475

1,241 views

Original Research

Published on 27 Mar 2023

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma

in Genitourinary Oncology

Yonghua Bi
Dechao Jiao
Jianhao Zhang
Jianzhuang Ren
Xinwei Han
Kefeng Guo
Xueliang Tu

Frontiers in Oncology

doi 10.3389/fonc.2023.1081258

565 views

Original Research

Published on 24 Mar 2023

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma

in Genitourinary Oncology

Wei Zhang
Wenqiang Liu
Yiren Yang
Chengwu Xiao
Yutian Xiao
Xiaojie Tan
Qingyang Pang
Han Wu
Meimian Hua
Xiaolei Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1102623

1,130 views
1 citation

Navigation group

Articles

A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer

Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours

Erectile function, urinary continence and oncologic outcomes of neurovascular bundle sparing robot-assisted radical prostatectomy for high-risk prostate cancer: A systematic review and meta-analysis

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma

Primary squamous cell carcinoma of renal parenchyma: A case report and literature review

Malignant glomus tumor of prostate: A case report

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

Identifying novel biomarkers associated with bladder cancer treatment outcomes

Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer

Risk of malignancy in adrenal tumors in patients with a history of cancer

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma